SCHEMBL19082031

SCHEMBL19082031

c1ccc2c(-c3c4ccccc4c(-c4ccc(-c5ccc6sc7cc8c(cc7c6c5)oc5c6ccccc6ccc85)c5ccccc45)c4ccccc34)cccc2c1

nearest known ligand 0.35

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 1/20 0.34
ARSA P15289 1/20 0.34
CDC25A P30304 1/20 0.34
CDC25C P30307 1/20 0.34
CYP1A1 P04798 7/20 0.33
CYP1B1 Q16678 7/20 0.33
PSD A5PKW4 1/20 0.33
CA12 O43570 1/20 0.33
CA1 P00915 1/20 0.33
CA2 P00918 1/20 0.33
CA9 Q16790 1/20 0.33
CYP1A2 P05177 6/20 0.32
PSMD14 O00487 1/20 0.32
CSNK2A2 P19784 1/20 0.32
CSNK2B P67870 1/20 0.32
CSNK2A1 P68400 1/20 0.32
TDP1 Q9NUW8 1/20 0.32
PRKDC P78527 1/20 0.32
XDH P47989 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19081852 0.91 CYP1A1 (0.36) ARSACDC25ACDC25CCYP1A1CYP1B1
SCHEMBL19110043 0.90 ALOX5 (0.40) ALOX5ARSACDC25ACDC25CCYP1A1
SCHEMBL24342070 0.88 ALOX5 (0.40) ALOX5ARSACDC25ACDC25CCYP1A1
SCHEMBL24343116 0.87 ALOX5 (0.34) ALOX5ARSACDC25ACDC25CPRKDC
SCHEMBL19081637 0.87 ALOX5 (0.40) ALOX5ARSACDC25ACDC25CCYP1A1
SCHEMBL17944506 0.85 ALOX5 (0.43) ALOX5ARSACDC25ACDC25CCYP1A1
SCHEMBL19082035 0.85 ARSA (0.34) ARSACDC25ACDC25CCYP1A1CYP1B1
SCHEMBL19080210 0.85 CYP1A1 (0.32) ALOX5CYP1A1CYP1B1PSD
SCHEMBL19081794 0.84 CYP1A1 (0.43) CYP1A1CYP1B1CYP1A2PSMD14CSNK2A2
SCHEMBL19108811 0.84 ALOX5 (0.38) ALOX5CYP1A1CYP1B1PSDPRKDC

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10553800-B2 Condensed cyclic compound and an organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2020-02-04 US disclosed
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10553800-B2 Condensed cyclic compound and an organic light-emitting device including the same CRY1, CRY2, CCNT1 ALOX5 1939/4885ARSA 4543/4885CDC25A 71/4885
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNT1 ALOX5 1939/4885ARSA 4543/4885CDC25A 71/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.